Showing results (1581-1590 of 2,038) with videos related to

Sort By:
Pageof 204
Zhonghua Yi Xue Za Zhi|June 25, 2020
[Clinical analysis of mediastinal lymph node dissection through sternotomy approach in the treatment of papillary thyroid carcinoma with mediastinal lymph node metastasis]K Shao, S G Gao, Q Xue, et al.
European Urology|April 12, 2021
Prostate-specific Membrane Antigen and Fluciclovine Transporter Genes are Associated with Variable Clinical Features and Molecular Subtypes of Primary Prostate CancerCarissa E Chu, Mohammed Alshalalfa, Martin Sjöström, et al.
Cancer Research|February 7, 2023
DNA Methylation Landscapes of Prostate Cancer Brain Metastasis Are Shaped by Early Driver Genetic AlterationsJohn Gallon, Antonio Rodriguez-Calero, Andrej Benjak, et al.
The British Journal of Dermatology|September 28, 2021
Adcitmer<sup>®</sup> , a new CD56-targeting monomethyl auristatin E-conjugated antibody, is a potential therapeutic approach in Merkel cell carcinomaC Esnault, V Leblond, C Martin, et al.
European Urology Oncology|May 18, 2019
Impact of Biochemical Failure After Salvage Radiation Therapy on Prostate Cancer-specific Mortality: Competition Between Age and Time to Biochemical FailureWilliam C Jackson, Krithika Suresh, Vasu Tumati, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 25, 2016
Frequent PD-L1 expression in primary and metastatic penile squamous cell carcinoma: potential opportunities for immunotherapeutic approachesA M Udager, T-Y Liu, S L Skala, et al.
European Urology Oncology|July 13, 2023
Long-term Outcomes of Chemoradiation for Muscle-invasive Bladder Cancer in Noncystectomy Candidates. Final Results of NRG Oncology RTOG 0524-A Phase 1/2 Trial of Paclitaxel + Trastuzumab with Daily Radiation or Paclitaxel Alone with Daily IrradiationDouglas M Dahl, Theodore G Karrison, M Dror Michaelson, et al.
JCI Insight|May 23, 2022
Response to supraphysiological testosterone is predicted by a distinct androgen receptor cistromeXintao Qiu, Lisha G Brown, Jennifer L Conner, et al.
Cell|June 16, 2018
Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate CancerYi-Mi Wu, Marcin Cieślik, Robert J Lonigro, et al.
European Urology|January 8, 2018
Intermediate Endpoints After Postprostatectomy Radiotherapy: 5-Year Distant Metastasis to Predict Overall SurvivalWilliam C Jackson, Krithika Suresh, Vasu Tumati, et al.
Pageof 204